Jorge Sousa

Dr. Jorge Sousa


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Biology
Verified
Journal Article
Open access
PDF file
PNPablo Neves
Pablo Neves
Juarez Antonio Simões QuaresmaJuarez Antonio Simões Quaresma
Juarez Antonio Simões Quaresma
MQMARIA ALICE QUEIROZ
MARIA ALICE QUEIROZ
Camilla Costa SilvaCamilla Costa Silva
Camilla Costa Silva
EMEnzo Varela Maia
Enzo Varela Maia
LFLuiz Fábio Magno Falcão
Luiz Fábio Magno Falcão
A persistent state of inflammation has been reported during the COVID-19 pandemic. This study aimed to assess short-term heart rate variability (HRV), peripheral body temperature, and serum cytokine levels in patients with long COVID. We evaluated 202 patients with long COVID symptoms categorized them according to the duration of their COVID symptoms (≤120 days, n = 81; >120 days, n = 121), in addition to 95 healthy individuals selected as controls. All HRV variables differed significantly between the control group and patients with long COVID in the ≤120 days group (p < 0.05), and participants in the long COVID ≤120 days group had higher temperatures than those in the long COVID >120 days group in all regions analysed (p < 0.05). Cytokine analysis showed higher levels of interleukin 17 (IL-17) and interleukin 2 (IL-2), and lower levels of interleukin 4 (IL-4) (p < 0.05). Our results suggest a reduction in parasympathetic activation during long COVID and an increase in body temperature due to possible endothelial damage caused by the maintenance of elevated levels of inflammatory mediators. Furthermore, high serum levels of IL-17 and IL-2 and low levels of IL-4 appear to constitute a long-term profile of COVID-19 cytokines, and these markers are potential targets for long COVID-treatment and prevention strategies.

17 December 2025 in APMIS
Verified
Journal Article
Open access
CMCarla Menezes
Carla Menezes
LMLívia Martins
Lívia Martins
GFGustavo Batista Ferro
Gustavo Batista Ferro
BABernard Arnaud
Bernard Arnaud
Juarez Antonio Simões QuaresmaJuarez Antonio Simões Quaresma
Juarez Antonio Simões Quaresma
JSJorge Sousa
Jorge Sousa
Since its identification in 1947 and its global emergence in the Americas decades later, the Zika virus ( ZIKV ) has proven to be a multifaceted challenge to public health. Among the many aspects that remain poorly understood, the complex immunological paradox between Th1 and Th2 responses stands out, playing a central role in the immunopathogenesis of the infection. This narrative review critically explores how scientific literature has addressed this duality, highlighting that an exacerbated Th1 response—although effective in viral containment—is frequently associated with severe outcomes, such as heightened inflammation and autoimmune manifestations, including Guillain‐Barré syndrome. Conversely, a predominant Th2 profile, generally linked to milder clinical presentations, may favor viral persistence and, paradoxically, contribute to late‐onset neurological complications, such as encephalitis. Additionally, we discuss the central role of interactions between CD4 + and CD8 + T cells, monocytes, NK cells, and B cells, which, although essential for immune control of the infection, may, when dysregulated, exacerbate pathogenesis. By unraveling the mechanisms behind this delicate balance between antiviral defense and immune‐mediated damage, we aim to shed light on new therapeutic perspectives. Understanding the nature and consequences of this Th1/Th2 paradox is crucial for guiding the development of immunomodulatory strategies that foster an effective response against ZIKV , while minimizing the risk of neurological injury.

9 October 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
TQTATIANE COSTA QUARESMA
TATIANE COSTA QUARESMA
LVLívia Valentim
Lívia Valentim
JSJorge Sousa
Jorge Sousa
TATinara Leila de Souza Aarão
Tinara Leila de Souza Aarão
HFHellen Fuzii
Hellen Fuzii
Juarez Antonio Simões QuaresmaJuarez Antonio Simões Quaresma
Juarez Antonio Simões Quaresma
Mycobacterium leprae is the etiological agent of leprosy. Macrophages (Mφs) are key players involved in the pathogenesis of leprosy. In this study, immunohistochemical analysis was performed to examine the phenotype of Mφ subpopulations, namely M1, M2, and M4, in the skin lesions of patients diagnosed with leprosy. Based on the database of treatment-naïve patients treated between 2015 and 2019 at the Department of Dermatology of the University of the State of Pará, Belém, routine clinical screening samples were identified. The monolabeling protocol was used for M1 macrophages (iNOS, IL-6, TNF-α) and M2 macrophages (IL-10, IL-13, CD163, Arginase 1, TGF-β, FGFb), and the double-labeling protocol was used for M4 macrophages (IL-6, MMP7, MRP8, TNF-α e CD68). To confirm the M4 macrophage lineage, double labeling of the monoclonal antibodies CD68 and MRP8 was also performed. Our results demonstrated a statistically significant difference for the M1 phenotype among the Virchowian (VV) (4.5 ± 1.3, p < 0.0001), Borderline (1.6 ± 0.4, p < 0.0001), and tuberculoid (TT) (12.5 ± 1.8, p < 0.0001) clinical forms of leprosy. Additionally, the M2 phenotype showed a statistically significant difference among the VV (12.5 ± 2.3, p < 0.0001), Borderline (1.3 ± 0.2, p < 0.0001), and TT (3.2 ± 0.7, p < 0.0001) forms. For the M4 phenotype, a statistically significant difference was observed in the VV (9.8 ± 1.7, p < 0.0001), Borderline (1.2 ± 0.2, p < 0.0001), and TT (2.6 ± 0.7, p < 0.0001) forms. A significant correlation was observed between the VV M1 and M4 (r = 0.8712; p = 0.0000) and between the VV M2 × TT M1 (r = 0.834; p = 0.0002) phenotypes. The M1 Mφs constituted the predominant Mφ subpopulation in the TT and Borderline forms of leprosy, whereas the M2 Mφs showed increased immunoexpression and M4 was the predominant Mφ phenotype in VV leprosy. These results confirm the relationship of the Mφ profile with chronic pathological processes of the inflammatory response in leprosy.

Verified
Journal Article
Open access
PDF file
JSJorge Sousa
Jorge Sousa
LMLívia Carício Martins
Lívia Carício Martins
JMJulia Moura
Julia Moura
APAmanda Pereira
Amanda Pereira
BVBarbara Baldez Vasconcelos
Barbara Baldez Vasconcelos
Juarez Antonio Simões QuaresmaJuarez Antonio Simões Quaresma
Juarez Antonio Simões Quaresma
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a severe pulmonary disease with high mortality, particularly in low-income countries. Early diagnosis and timely treatment, including both intensive and maintenance phases, are critical for controlling the disease and preventing its transmission. In Brazil, where TB incidence remains high, thousands of new cases are reported annually. Transmission occurs primarily through airborne droplets expelled by infected individuals. The immune response involves various cell types, such as lymphocytes and macrophages, which form granulomas to limit the spread of the bacillus. Upon entering the lungs, Mtb is phagocytosed by immune cells, where it evades destruction by blocking phagolysosome formation and inhibiting phagosome acidification. In response, the immune system forms granulomas that contain the infection, although these can become reactivated if immune function deteriorates. Mtb also interferes with host cellular organelles, particularly the endoplasmic reticulum (ER) and mitochondria, inducing cellular stress and apoptosis, which aids in its survival. Key Mtb-secreted proteins, such as BAG2 and CdhM, modulate autophagy and apoptosis pathways, influencing pathogen survival within immune cells. A deeper understanding of these molecular mechanisms, particularly the role of ER stress and its impact on immune responses, is essential for developing novel therapeutic strategies for TB prevention and treatment.

5 November 2026 in Immunologic Research
Verified
Journal Article
Open access
BLBaraci da Silva Lima
Baraci da Silva Lima
YSYan Thiago Paes dos Santos
Yan Thiago Paes dos Santos
GFGabriel Costa Farias
Gabriel Costa Farias
ESElionai Felipe Rocha de Lima Souza
Elionai Felipe Rocha de Lima Souza
PLPatricia Lima
Patricia Lima
JSJorge Sousa
Jorge Sousa
Alzheimer’s disease (AD) is increasingly recognized as a multicellular neuroimmune disorder in which proteostatic failure, metabolic dysfunction, and sustained glial activation interact to accelerate synaptic loss. This narrative review examines endoplasmic reticulum (ER) stress in astrocytes as a mechanistic link among the unfolded protein response (UPR), neuroinflammation, mitochondrial dysfunction, and neurodegeneration. The three canonical UPR branches, mediated by protein kinase R-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6 (ATF6), initially reduce protein-folding burden and reinforce ER quality control. When stress persists and adaptive capacity becomes insufficient, sustained PERK and IRE1 signaling may favor apoptosis, inflammatory transcriptional programs, cytokine production, calcium dyshomeostasis, and oxidative injury, whereas ATF6 remains predominantly associated with proteostatic reinforcement in a context-dependent manner. In astrocytes, persistent UPR activation may impair neuronal metabolic support, synaptogenic signaling, and astrocytic contributions to neurovascular homeostasis while promoting complement component 3 (C3) expression and bidirectional inflammatory crosstalk with microglia. ER-mitochondria contact sites further integrate calcium transfer, reactive oxygen species generation, bioenergetic failure, and intrinsic apoptotic signaling. Experimental evidence therefore supports a self-reinforcing neuroglial circuit in which astrocytic ER stress is proposed to function as an amplifier rather than merely a consequence of AD pathology. Therapeutic strategies targeting UPR signaling, chemical chaperones, extracellular vesicles, gene modulation, and cell-selective delivery systems remain under investigation, and their translation will require temporally controlled, cell-type-specific, and safety-conscious modulation of stress responses.

27 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
GAGabriela Maria Coimbra Coelho de Assis
Gabriela Maria Coimbra Coelho de Assis
IVIan Gonçalves da Veiga
Ian Gonçalves da Veiga
RRRita de Nazaré Rayol Reis
Rita de Nazaré Rayol Reis
DMDaniel Carvalho de Menezes
Daniel Carvalho de Menezes
SXStanley Soares Xavier
Stanley Soares Xavier
PLPatricia Lima
Patricia Lima
Long coronavirus disease 2019 (COVID-19) may occur after experiencing acute COVID-19 infec-tion with many effects on patients´ kidneys. This study aimed to evaluate the clinical and labora-tory aspects of kidney function in individuals with long COVID in the Amazon region of Brazil. This cross-sectional study selected participants from a ‘long COVID’ clinical care program. Clini-cal data and baseline demographics were obtained, and blood samples were collected to quantify kidney-related markers. Patients were evaluated after COVID-19 infection at several time points as follows: 0–3 months, 3–6 months, 6–12 months, and 12 months. Altogether, 246 patients were selected for this study, and only 79 were hospitalised (9 in the intensive care unit because of COVID-19. Of the patients, 38 were diagnosed with hypertension after COVID-19, 52 cases had to have their medications adjusted, and 83 patients presented with kidney function decline. The older age group and individuals with glycaemic alterations presented with a higher risk of devel-oping kidney dysfunction. Therefore, health professionals should monitor long-term kidney mark-ers in long COVID.